423 results on '"de‐Torres, Juan P."'
Search Results
2. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
3. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins
4. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
5. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
6. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
7. New or enlarging hiatal hernias after thoracic surgery for early lung cancer
8. Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
9. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
10. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD
11. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
12. Temperature-guided ablation with the second-generation cryoballoon for paroxysmal atrial fibrillation: 3-year follow-up in a multicenter experience
13. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
14. Sex differences between women and men with COPD: A new analysis of the 3CIA study
15. Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
16. Dyspnea in COPD: New Mechanistic Insights and Management Implications
17. Prognostic Validation Using GesEPOC 2017 Severity Criteria
18. Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm
19. Temporal transitions in COPD severity stages within the GOLD 2017 classification system
20. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
21. Chronic Obstructive Pulmonary Disease in Women. Is it Different?
22. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO.
23. Acute pericarditis following second-generation cryoballoon ablation for atrial fibrillation
24. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial): A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment
25. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
26. Plasma metabolomics and clinical predictors of survival differences in COPD patients
27. Online Data Supplement: Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
28. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
29. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients.
30. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease.
31. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)
32. Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports: Impact on Grouping and Outcomes
33. Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease
34. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study
35. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation
36. Chronic Obstructive Pulmonary Disease History Assessment in Spain: A Multidimensional Chronic Obstructive Pulmonary Disease Evaluation. Study Methods and Organization
37. Neurophysiological mechanisms of exertional dyspnea in post-pulmonary embolism syndrome.
38. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
39. Robust, Standardized Quantification of Pulmonary Emphysema in Low Dose CT Exams
40. Emphysema Presence, Severity, and Distribution Has Little Impact on the Clinical Presentation of a Cohort of Patients With Mild to Moderate COPD
41. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort
42. Continuous Monitoring of Pulse Oximetry During the 6-MinuteWalk Test Improves Clinical Outcomes Prediction in COPD.
43. Diagnostic Yield of Electromagnetic Navigation Bronchoscopy Is Highly Dependent on the Presence of a Bronchus Sign on CT Imaging: Results From a Prospective Study
44. Effect of Stent Thrombosis on the Risk-Benefit Balance of Drug-Eluting Stents and Bare Metal Stents
45. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD
46. Lung Cancer Screening: The Balance between Harm and Benefit
47. Improving Selection Criteria for Lung Cancer Screening. The Potential Role of Emphysema
48. Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. Development and Validation of the COPD Lung Cancer Screening Score
49. Exertional dyspnoea in patients with mild‐to‐severe chronic obstructive pulmonary disease: neuromechanical mechanisms.
50. Physiological predictors of morbidity and mortality in COPD: the relative importance of reduced inspiratory capacity and inspiratory muscle strength.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.